Lisata Therapeutics clinical trials we track

Check company identity source

Phase 2 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 5 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Incidence of adverse events. After: Measure: Number of Subjects Experiencing Any Adverse Event.

Actual enrollment decreased by 1 participants

Before: 67 participants (actual). After: 66 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 18 Apr 2026. After: 5 Apr 2026.

Recruitment status changed

Before: Active not recruiting. After: Terminated.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change From Baseline in Angina Frequency Measure: Change From Baseline in CCS Angina Class Measure: Change From Baseline in Total Exercise Time Measure: Change From Baseline in Health-related Quality of Life (HRQoL). After: Measure: Change From Baseline in Number of Angina Attacks Per Week Measure: Change From Baseline in CCS Angina Class Measure: Change From Baseline in Total Exercise Time Measure: Change From Baseline in Health-related Quality of Life (HRQoL).

Check registry source